Application of Single-Cell Genomics to Animal Models of Periodontitis and Peri-Implantitis
- PMID: 39695834
- PMCID: PMC11743042
- DOI: 10.1111/jcpe.14093
Application of Single-Cell Genomics to Animal Models of Periodontitis and Peri-Implantitis
Abstract
Aims: This narrative review aims to synthesize current knowledge on integrating single-cell genomics technologies with animal models of periodontitis and peri-implantitis.
Review: Single-cell RNA sequencing (scRNAseq) reveals cellular heterogeneity and specific cell roles in periodontitis and peri-implantitis, overcoming the limitations of bulk RNA sequencing. Under controlled conditions and genetic manipulation, animal models facilitate studying disease progression, gene functions and systemic disease links, aiding targeted therapy development. Knockout models have started to elucidate the impact of genetic mutations on periodontal disease and host responses. scRNAseq in animal models has been used to examine connections between periodontitis and systemic diseases, revealing altered immune environments and cellular interactions. Emerging studies are now applying these methods to animal models of peri-implantitis. Integrating these datasets into single-cell and spatially resolved atlases will enable future meta-analyses, providing deeper insights into disease mechanisms considering factors such as sex, strain, and age.
Conclusions: Integrating scRNAseq with animal models advances the understanding of periodontitis and peri-implantitis pathogenesis and precision therapies. The combined use of single-cell and spatial genomics and scRNAseq will further enhance data insights significantly for drug discovery and preclinical testing, making these technologies pivotal in validating animal models and translating findings into clinical practice.
Keywords: animal models; periodontitis; peri‐implantitis spatial biology; single‐cell RNA sequencing.
© 2024 The Author(s). Journal of Clinical Periodontology published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors had access to the manuscript and approved the final manuscript. The authors declare that this study was conducted without any commercial or financial relationships that could be construed as potential conflicts of interest. We report that A.H., Q.T.E., and K.M.B. are active members of the Human Cell Atlas. In addition, K.M.B. is a Scientific Advisor at Arcato Laboratories Inc. (Durham, NC, USA). The author views this as a non‐competing financial interest.
Figures
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
